Invention Grant
![Antibacterial cyclopenta[C]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinones](/docs/US/2020-01-07/US10526331B2/abs.jpg.600x600.jpg)
- Patent Title: Antibacterial cyclopenta[C]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinones
-
Application No.: US16286383Application Date: 2019-02-26
-
Publication No.: US10526331B2Publication Date: 2020-01-07
- Inventor: Jerôme Emile Georges Guillemont , David Francis Alain Lançois , Magali Madeleine Simone Motte , Anil Koul , Wendy Mia Albert Balemans , Eric Pierre Alexandre Arnoult
- Applicant: Janssen Sciences Ireland Unlimited Company
- Applicant Address: IE Co Cork
- Assignee: Janssen Sciences Ireland Unlimited Company
- Current Assignee: Janssen Sciences Ireland Unlimited Company
- Current Assignee Address: IE Co Cork
- Priority: EP11177119 20110810
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K31/50 ; A61K31/495 ; A61K31/44 ; C07D487/04 ; C07D519/00
![Antibacterial cyclopenta[C]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinones](/abs-image/US/2020/01/07/US10526331B2/abs.jpg.150x150.jpg)
Abstract:
The present invention is related to novel compounds of formula (I) that inhibit the activity of the FabI enzyme which are therefore useful in the treatment of bacterial infections. It further relates to pharmaceutical compositions comprising these compounds, and chemical processes for preparing these compounds.
Public/Granted literature
- US20190194194A1 ANTIBACTERIAL CYCLOPENTA[C]PYRROLE SUBSTITUTED 3,4-DIHYDRO-1H-[1,8]NAPHTHYRIDINONES Public/Granted day:2019-06-27
Information query
